BXP Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

BXP şirketinin toplam hissedar öz sermayesi $8.3B ve toplam borcu $16.2B olup, bu da borç-öz sermaye oranını 196.2% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $26.4B ve $18.1B dir. BXP 'in FAVÖK'ü $1.0B faiz karşılama oranı 1.8 dur. Şirketin $1.4B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

196.2%

Borç/özkaynak oranı

US$16.23b

Borç

Faiz karşılama oranı	1.8x
Nakit	US$1.42b
Eşitlik	US$8.27b
Toplam yükümlülükler	US$18.13b
Toplam varlıklar	US$26.41b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

BXP, Inc.: Easy Money Has Been Made (Rating Downgrade)

Oct 04

BXP, Inc.: A Well-Covered 6% Yield From A Premier Office REIT

Jul 19

Boston Properties: Tentative Signs The Office Market Is Getting Less Weak (Rating Upgrade)

Jun 07

Boston Properties FFO of $1.91 beats by $0.04, revenue of $790.52M beats by $27.84M

Oct 25

Boston Properties: My Oh My, A Blue-Chip Strong Buy

Oct 02

Boston Properties declares $0.98 dividend

Sep 16

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BXP 'nin kısa vadeli varlıkları ( $3.2B ) kısa vadeli yükümlülüklerini ( $3.3B ) kapsamıyor.

Uzun Vadeli Yükümlülükler: BXP 'un kısa vadeli varlıkları ( $3.2B ) uzun vadeli yükümlülüklerini ( $14.8B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BXP 'nin net borç/öz sermaye oranı ( 179% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: BXP şirketinin borç/öz sermaye oranı son 5 yılda 148.1% seviyesinden 196.2% seviyesine yükseldi.

Borç Kapsamı: BXP 'nin borcu işletme nakit akışı ( 7.6% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: BXP 'in borcuna ilişkin faiz ödemeleri EBIT ( 1.8 x kapsam) tarafından iyi karşılanmıyor.

BXP Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Now 20% undervalued

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

BXP, Inc. Updates Earnings Guidance for the Full Year of 2024

BXP, Inc.: Easy Money Has Been Made (Rating Downgrade)

BXP, Inc. to Report Q3, 2024 Results on Oct 29, 2024

Upcoming dividend of US$0.98 per share

Now 20% undervalued

Senior Executive Vice President recently sold US$1.6m worth of stock

Second quarter dividend of US$0.98 announced

Senior Executive Vice President notifies of intention to sell stock

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

BXP, Inc.: A Well-Covered 6% Yield From A Premier Office REIT

BXP, Inc. to Report Q2, 2024 Results on Jul 30, 2024

First quarter dividend of US$0.98 announced

Boston Properties, Inc. Declares Quarterly Cash Dividend for the Period April 1, 2024 to June 30, 2024, Payable on July 31, 2024

Boston Properties: Tentative Signs The Office Market Is Getting Less Weak (Rating Upgrade)

First quarter 2024 earnings: EPS in line with analyst expectations despite revenue beat

Boston Properties, Inc. Provides Earnings Guidance for the Second Quarter of Fiscal 2024 and Full Year 2024

Boston Properties, Inc., Annual General Meeting, May 22, 2024

Now 23% undervalued after recent price drop

Boston Properties, Inc. to Report Q1, 2024 Results on Apr 30, 2024

Boston Properties: Superior Property Portfolio But Office Outlook Remains Weak

Now 22% undervalued after recent price drop

Fourth quarter dividend of US$0.98 announced

Boston Properties, Inc. Declares Regular Quarterly Dividend, Payable on April 30, 2024

Senior Executive Vice President recently sold US$889k worth of stock

Now 21% undervalued

Boston Properties, Inc. Provides Earnings Guidance for the First Quarter of 2024 and Fiscal Year 2024

Full year 2023 earnings: EPS misses analyst expectations

Office Mayhem: Why 6%-Yielding Boston Properties Remains A Hard Pass For Me

Boston Properties, Inc. to Report Q4, 2023 Results on Jan 30, 2024

Boston Properties, Inc. Declares Regular Quarterly Cash Dividend, Payable on January 30, 2024

Investor sentiment improves as stock rises 18%

Consensus EPS estimates fall by 14%

Norges Bank Investment Management entered into agreement to acquire 45% stake in Life Sciences Development Properties Located in Kendall Square in Cambridge, Massachusetts from Boston Properties, Inc. (NYSE:BXP) for $210 million.

Boston Properties: Higher Rates And Lower Occupancy Are Significant Headwinds

Consensus EPS estimates fall by 14%

Third quarter 2023 earnings: EPS misses analyst expectations

Boston Properties, Inc. Provides Updated Earnings Guidance for Full Year 2023

Clark Construction Group Joins Representatives from BXP to Celebrate the Topping Out of Skymark Reston Town Center

7% Yield And Mounting Risks - A Closer Look At Boston Properties

Boston Properties, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Upcoming dividend of US$0.98 per share at 6.0% yield

Boston Properties - I Was Clear About The Upside

Senior Executive Vice President recently sold US$4.4m worth of stock

Boston Properties, Inc. Declares Regular Quarterly Dividend, Payable on October 31, 2023

Boston Properties: The Stock Has Become Fairly Valued

Price target increased by 7.0% to US$68.07

Boston Properties: Solid Leasing Improves The Outlook

Price target increased by 7.2% to US$68.07

New major risk - Revenue and earnings growth

Boston Properties: Solid Q2 Result Reassures Solid Dividend Yield

Boston Properties, Inc. Board Changes

BXP Announces Executive Changes

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% undervalued

Boston Properties, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Boston Properties: Don't Listen To The Doomsayers, It Is Here To Stay

Now 23% undervalued

Boston Properties, Inc. Declares Regular Quarterly Cash Dividend for the Period April 1, 2023 to June 30, 2023, Payable on July 31, 2023

Boston Properties: The Question Of Upside Or Income

New minor risk - Insider selling

Insider recently sold US$571k worth of stock

Boston Properties: Hefty 8% Yield On This Contrarian Bet

Independent Director recently bought US$474k worth of stock

High number of new directors

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Price target decreased by 8.5% to US$71.37

Price target decreased by 8.8% to US$72.89

Independent Director recently bought US$529k worth of stock

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Full year 2022 earnings: EPS and revenues exceed analyst expectations